Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022

人工神経(神経機能代替) の世界市場予測(~2022年)

◆タイトル:Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022
◆商品コード:MAM-MD-5908
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年1月22日
◆ページ数:120
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、人工神経(神経機能代替) の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、技術別分析、用途別分析、地域別分析、人工神経(神経機能代替) の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Neuroprosthetics market projected to grow at a CAGR of 12.4%”The neuroprosthetics market was valued at USD 5.84 billion in 2017 and expected to grow at a CAGR of 12.4% to a USD 10.48 billion market by 2022. Factors driving this market include increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries. Availability of alternative treatment, high cost of neuroprosthetics devices, and dearth of trained professionals are the major factors hampering the growth of the market.
“Output neural prosthetics segment is accounted for the largest share in the market”
The neuroprosthetics market is classified on the basis of type into input neural prosthetics and output neural prosthetics. The output neural prosthetics segment accounted for the largest share of this market segment. This growth can be attributed to the increasing neurological disorders.
“Motor neuron disorders segment is expected to register the highest CAGR during the forecast period”
The neuroprosthetics market is classified on the basis of the application into motor neuron disorders, physiological disorders, and cognitive disorders. The motor neuron disorders segment is expected to register the highest growth rate during the forecast period. This growth can be attributed to the increasing neurological disorders such as Parkinson’s disease and epilepsy.
“North America is account for the largest regional segment in the market”
Geographically, the neuroprosthetics market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region and rising geriatric population, increasing incidence of peripheral nerve injuries, availability of government funding, and technological advancements.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1 – 35%, Tier 2 – 22% and Tier 3 – 43%
• By Designation – C level – 15%, Director level – 32%, Others – 53%
• By Region – North America – 32%, Europe – 27%, Asia – 22%, RoW – 19%

Key players operating in the neuroprosthetics market include Medtronic (US), Boston Scientific (US), Abbott (US), LivaNova (UK), Secong Sight (US), and Cochlear (Australia).
Research Coverage:
The report analyses the neuroprosthetics market by type, technique, application, and region. Apart from comprehensive geographic and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The abovementioned market research data, market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.
Benefits of Buying this Report:
This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

• Market Penetration: The report analyzes the neuroprosthetics market on the basis of several segments.
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the neuroprosthetics market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various neuroprosthetics product across geographies.
• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the neuroprosthetics market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 DEFINITION 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
1.4 YEARS CONSIDERED FOR THE STUDY 13
1.5 CURRENCY 14
1.6 LIMITATIONS 14
1.7 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 RESEARCH DATA 15
2.1.1 SECONDARY DATA 16
2.1.1.1 Key data from secondary sources 16
2.1.2 PRIMARY DATA 16
2.1.2.1 Key data from primary sources 17
2.1.2.2 Key Industry Insights 17
2.1.2.3 Breakdown of primaries 17
2.2 MARKET SIZE ESTIMATION 18
2.2.1 BOTTOM-UP APPROACH 18
2.2.2 TOP-DOWN APPROACH 19
2.3 DATA TRIANGULATION 20
2.4 ASSUMPTIONS 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 25
4.1 NEUROPROSTHETICS MARKET OVERVIEW 25
4.2 EUROPEAN OUTPUT NEURAL PROSTHETICS MARKET, BY APPLICATION AND COUNTRY 26
4.3 GEOGRAPHIC ANALYSIS OF THE NEUROPROSTHETICS MARKET, BY COUNTRY 27
4.4 OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE 28
5 MARKET OVERVIEW 29
5.1 INTRODUCTION 29
5.2 MARKET DYNAMICS 29
5.2.1 DRIVERS 30
5.2.1.1 Increasing number of patients suffering from neurological disorders and nerve injury 30
5.2.1.2 Increasing incidence of hearing loss 30
5.2.1.3 Increasing cases of amputation due to the rising number of accidents & injuries 31
5.2.1.4 Increasing prevalence of diabetes 32
5.2.2 RESTRAINTS 32
5.2.2.1 Availability of alternative treatment options 32
5.2.2.2 High cost of neuroprosthetics and unfavorable reimbursement scenario 32
5.2.2.3 Dearth of trained professionals 32
5.2.3 OPPORTUNITIES 33
5.2.3.1 Higher growth opportunities in emerging economies 33
5.2.3.2 Expanded target applications and new indications 33
6 NEUROPROSTHETICS MARKET, BY TYPE 34
6.1 INTRODUCTION 35
6.2 OUTPUT NEURAL PROSTHETICS 36
6.2.1 MOTOR PROSTHETICS 37
6.2.2 COGNITIVE PROSTHETICS 37
6.3 INPUT NEURAL PROSTHETICS 38
6.3.1 COCHLEAR IMPLANTS 39
6.3.2 BIONIC EYE/RETINAL IMPLANTS 40
7 NEUROPROSTHETICS MARKET, BY TECHNIQUE 41
7.1 INTRODUCTION 42
7.2 SPINAL CORD STIMULATION 43
7.3 DEEP BRAIN STIMULATION 43
7.4 VAGUS NERVE STIMULATION 44
7.5 SACRAL NERVE STIMULATION 45
7.6 TRANSCRANIAL MAGNETIC STIMULATION 45
8 NEUROPROSTHETICS MARKET, BY APPLICATION 47
8.1 INTRODUCTION 48
8.2 MOTOR NEURON DISORDERS 49
8.2.1 PARKINSON’S DISEASE 50
8.2.2 EPILEPSY 50
8.3 PHYSIOLOGICAL DISORDERS 51
8.3.1 AUDITORY PROCESSING DISORDERS 52
8.3.2 OPHTHALMIC DISORDERS 53
8.3.3 CARDIOVASCULAR DISORDERS 53
8.3.4 UROLOGY DISORDERS 54
8.4 COGNITIVE DISORDERS 55
8.4.1 ALZHEIMER’S DISEASE 56
8.4.2 PARALYSIS 56
9 NEUROPROSTHETICS MARKET, BY REGION 57
9.1 INTRODUCTION 58
9.2 NORTH AMERICA 59
9.2.1 US 63
9.2.2 CANADA 65
9.3 EUROPE 66
9.3.1 GERMANY 70
9.3.2 UK 72
9.3.3 FRANCE 73
9.3.4 REST OF EUROPE 74
9.4 ASIA PACIFIC 76
9.5 REST OF THE WORLD 80
10 COMPETITIVE LANDSCAPE 85
10.1 OVERVIEW 85
10.2 MARKET SHARE ANALYSIS, 2016 86
10.3 COMPETITIVE SCENARIO 87
10.3.1 PRODUCT LAUNCHES AND APPROVALS 87
10.3.2 ACQUISITIONS 87
10.3.3 AGREEMENTS 88
10.3.4 MERGERS 88
10.3.5 EXPANSIONS 88
11 COMPANY PROFILES 89
(Overview, Products Offered, Recent Developments, MnM View)*
11.1 MEDTRONIC 89
11.2 ABBOTT 91
11.3 COCHLEAR 94
11.4 BOSTON SCIENTIFIC 96
11.5 LIVANOVA 99
11.6 SECOND SIGHT 101
11.7 MED-EL 103
11.8 RETINA IMPLANT 104
11.9 SONOVA 105
11.10 NEUROPACE 107
11.11 NDI MEDICAL 108
11.12 NEVRO 109
*Details on Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 110
12.1 INDUSTRY INSIGHTS 110
12.2 DISCUSSION GUIDE 111
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 113
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 115
12.5 AVAILABLE CUSTOMIZATIONS 116
12.6 RELATED REPORTS 117
12.7 AUTHOR DETAILS 118

LIST OF TABLES

TABLE 1 INCIDENCE OF HEARING LOSS, BY REGION, 2012 (MILLION) 31
TABLE 2 NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 35
TABLE 3 OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 36
TABLE 4 OUTPUT NEURAL PROSTHETICS MARKET, BY REGION, 2015–2022 (USD MILLION) 36
TABLE 5 MOTOR PROSTHETICS MARKET, BY REGION, 2015–2022 (USD MILLION) 37
TABLE 6 COGNITIVE PROSTHETICS MARKET, BY REGION, 2015–2022 (USD MILLION) 38
TABLE 7 INPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 38
TABLE 8 INPUT NEURAL PROSTHETICS MARKET, BY REGION, 2015–2022 (USD MILLION) 39
TABLE 9 COCHLEAR IMPLANTS MARKET, BY REGION, 2015–2022 (USD MILLION) 39
TABLE 10 BIONIC EYE/RETINAL IMPLANTS MARKET, BY REGION, 2015–2022 (USD MILLION) 40
TABLE 11 NEUROPROSTHETICS MARKET, BY TECHNIQUE, 2015–2022 (USD MILLION) 42
TABLE 12 SPINAL CORD STIMULATION MARKET, BY REGION, 2015–2022 (USD MILLION) 43
TABLE 13 DEEP BRAIN STIMULATION MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 14 VAGUS NERVE STIMULATION MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 15 SACRAL NERVE STIMULATION MARKET, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 16 TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY REGION,
2015–2022 (USD MILLION) 46
TABLE 17 NEUROPROSTHETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 48
TABLE 18 NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY TYPE,
2015–2022 (USD MILLION) 49
TABLE 19 NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY REGION, 2015–2022 (USD MILLION) 49
TABLE 20 NEUROPROSTHETICS MARKET FOR PARKINSON’S DISEASE, BY REGION,
2015–2022 (USD MILLION) 50
TABLE 21 NEUROPROSTHETICS MARKET FOR EPILEPSY, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 22 NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE,
2015–2022 (USD MILLION) 51
TABLE 23 NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 24 NEUROPROSTHETICS MARKET FOR AUDITORY PROCESSING DISORDERS,
BY REGION, 2015–2022 (USD MILLION) 52
TABLE 25 NEUROPROSTHETICS MARKET FOR OPHTHALMIC DISORDERS, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 26 NEUROPROSTHETICS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2015–2022 (USD MILLION) 53
TABLE 27 NEUROPROSTHETICS MARKET FOR UROLOGY DISORDERS, BY REGION,
2015–2022 (USD MILLION) 54
TABLE 28 NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY TYPE,
2015–2022 (USD MILLION) 55
TABLE 29 NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY REGION,
2015–2022 (USD MILLION) 55
TABLE 30 NEUROPROSTHETICS MARKET FOR ALZHEIMER’S DISEASE, BY REGION,
2015–2022 (USD MILLION) 56
TABLE 31 NEUROPROSTHETICS MARKET FOR PARALYSIS, BY REGION,
2015–2022 (USD MILLION) 56
TABLE 32 NEUROPROSTHETICS MARKET, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 33 NORTH AMERICA: NEUROPROSTHETICS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 60
TABLE 34 NORTH AMERICA: NEUROPROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 60
TABLE 35 NORTH AMERICA: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 60
TABLE 36 NORTH AMERICA: INPUT NEURAL PROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 61
TABLE 37 NORTH AMERICA: NEUROPROSTHETICS MARKET, BY TECHNIQUE,
2015–2022 (USD MILLION) 61
TABLE 38 NORTH AMERICA: NEUROPROSTHETICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 61
TABLE 39 NORTH AMERICA: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY TYPE, 2015–2022 (USD MILLION) 62
TABLE 40 NORTH AMERICA: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2015–2022 (USD MILLION) 62
TABLE 41 NORTH AMERICA: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS,
BY TYPE, 2015–2022 (USD MILLION) 62
TABLE 42 US: NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 63
TABLE 43 US: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 64
TABLE 44 US: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 64
TABLE 45 CANADA: NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 65
TABLE 46 CANADA: NEUROPROSTHETICS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 65
TABLE 47 CANADA: NEUROPROSTHETICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 66
TABLE 48 EUROPE: NEUROPROSTHETICS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 67
TABLE 49 EUROPE: NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 68
TABLE 50 EUROPE: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 68
TABLE 51 EUROPE: INPUT NEURAL PROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 68
TABLE 52 EUROPE: NEUROPROSTHETICS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 69
TABLE 53 EUROPE: NEUROPROSTHETICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 69
TABLE 54 EUROPE: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS,
BY TYPE, 2015–2022 (USD MILLION) 69
TABLE 55 EUROPE: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS,
BY TYPE, 2015–2022 (USD MILLION) 70
TABLE 56 EUROPE: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS,
BY TYPE, 2015–2022 (USD MILLION) 70
TABLE 57 GERMANY: NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 71
TABLE 58 GERMANY: NEUROPROSTHETICS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 71
TABLE 59 GERMANY: NEUROPROSTHETICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 71
TABLE 60 UK: NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 72
TABLE 61 UK: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 72
TABLE 62 UK: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 73
TABLE 63 FRANCE: NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 73
TABLE 64 FRANCE: NEUROPROSTHETICS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 74
TABLE 65 FRANCE: NEUROPROSTHETICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 74
TABLE 66 REST OF EUROPE: NEUROPROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 75
TABLE 67 REST OF EUROPE: NEUROPROSTHETICS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 75
TABLE 68 REST OF EUROPE: NEUROPROSTHETICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 75
TABLE 69 ASIA PACIFIC: NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 77
TABLE 70 ASIA PACIFIC: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 78
TABLE 71 ASIA PACIFIC: INPUT NEURAL PROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 78
TABLE 72 ASIA PACIFIC: NEUROPROSTHETICS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 78
TABLE 73 ASIA PACIFIC: NEUROPROSTHETICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 79
TABLE 74 ASIA PACIFIC: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY TYPE, 2015–2022 (USD MILLION) 79
TABLE 75 ASIA PACIFIC: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS,
BY TYPE, 2015–2022 (USD MILLION) 79
TABLE 76 ASIA PACIFIC: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS,
BY TYPE, 2015–2022 (USD MILLION) 80
TABLE 77 ROW: NEUROPROSTHETICS MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 78 ROW: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 82
TABLE 79 ROW: INPUT NEURAL PROSTHETICS MARKET, BY TYPE,
2015–2022 (USD MILLION) 82
TABLE 80 ROW: NEUROPROSTHETICS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 82
TABLE 81 ROW: NEUROPROSTHETICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 83
TABLE 82 ROW: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS,
BY TYPE, 2015–2022 (USD MILLION) 83
TABLE 83 ROW: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS,
BY TYPE, 2015–2022 (USD MILLION) 83
TABLE 84 ROW: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY TYPE,
2015–2022 (USD MILLION) 84


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 15
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 18
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 4 DATA TRIANGULATION METHODOLOGY 20
FIGURE 5 NEUROPROSTHETICS MARKET, BY TYPE, 2017 VS. 2022 (USD BILLION) 22
FIGURE 6 NEUROPROSTHETICS MARKET, BY TECHNIQUE, 2017 VS. 2022 (USD BILLION) 23
FIGURE 7 NEUROPROSTHETICS MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION) 23
FIGURE 8 NEUROPROSTHETICS MARKET, BY REGION, 2017 VS. 2022 (USD BILLION) 24
FIGURE 9 RISING INCIDENCE OF HEARING LOSS AND GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE THE GROWTH OF THE MARKET 25
FIGURE 10 OUTPUT NEURAL PROSTHETICS TO DOMINATE THE EUROPEAN NEUROPROSTHETICS MARKET IN 2017 26
FIGURE 11 FRANCE TO REGISTER THE HIGHEST CAGR DURING THE FORECAST
PERIOD (2017–2022) 27
FIGURE 12 MOTOR PROSTHETICS WILL CONTINUE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2017-2022) 28
FIGURE 13 NEUROPROSTHETICS MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES 29
FIGURE 14 OUTPUT NEURAL PROSTHETICS SEGMENT TO DOMINATE THE MARKET BETWEEN 2017 AND 2022 35
FIGURE 15 SPINAL CORD STIMULATION, THE LARGEST TECHNIQUE SEGMENT IN THE MARKET 42
FIGURE 16 MOTOR NEURON DISORDERS SEGMENT TO DOMINATE THE NEUROPROSTHETICS MARKET DURING THE FORECAST PERIOD 48
FIGURE 17 NORTH AMERICA TO DOMINATE THE NEUROPROSTHETICS MARKET IN 2017 58
FIGURE 18 NORTH AMERICA: NEUROPROSTHETICS MARKET SNAPSHOT 59
FIGURE 19 EUROPE: NEUROPROSTHETICS MARKET SNAPSHOT 67
FIGURE 20 ASIA PACIFIC: NEUROPROSTHETICS MARKET SNAPSHOT 77
FIGURE 21 ROW: NEUROPROSTHETICS MARKET SNAPSHOT 81
FIGURE 22 PRODUCT APPROVALS & LAUNCHES- KEY STRATEGY ADOPTED BY PLAYERS BETWEEN 2014 AND 2017 85
FIGURE 23 SHARE OF COMPANIES IN THE NEUROPROSTHETICS MARKET, 2016 86
FIGURE 24 MEDTRONIC: COMPANY SNAPSHOT 89
FIGURE 25 ABBOTT: COMPANY SNAPSHOT 91
FIGURE 26 COCHLEAR: COMPANY SNAPSHOT 94
FIGURE 27 BOSTON SCIENTIFIC: COMPANY SNAPSHOT 96
FIGURE 28 LIVANOVA: COMPANY SNAPSHOT 99
FIGURE 29 SECOND SIGHT: COMPANY SNAPSHOT 101
FIGURE 30 SONOVA: COMPANY SNAPSHOT 105
FIGURE 31 NEVRO: COMPANY SNAPSHOT 109


【レポートのキーワード】

人工神経、神経機能代替

★調査レポート[人工神経(神経機能代替) の世界市場予測(~2022年)] ( Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022 / MAM-MD-5908) 販売に関する免責事項
[人工神経(神経機能代替) の世界市場予測(~2022年)] ( Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022 / MAM-MD-5908) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆